| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH11 SPATA31A3 MYO7B MYH7B SPATA31A7 TRPC5 CEP57L1 NUMA1 SAXO2 KATNAL1 SPATA31A6 SPATA31A5 MYO3A LLGL2 SPATA31A1 KIF2B BRCA2 FMN1 WASF2 MYO3B SYNE2 TRIM63 LSP1 CFAP157 | 6.55e-06 | 1099 | 159 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH11 SPATA31A3 MYO7B MYH7B SPATA31A7 TRPC5 SPATA31A6 SPATA31A5 MYO3A SPATA31A1 FMN1 WASF2 MYO3B SYNE2 LSP1 | 6.94e-06 | 479 | 159 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.22e-05 | 38 | 159 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RASGRP4 RAPGEF6 SGSM1 ARHGAP23 ADGRB3 RALGAPA2 RGS3 LLGL2 TBC1D14 THG1L BCAR3 ARHGAP20 DNMBP | 2.17e-04 | 507 | 159 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RASGRP4 RAPGEF6 SGSM1 ARHGAP23 ADGRB3 RALGAPA2 RGS3 LLGL2 TBC1D14 THG1L BCAR3 ARHGAP20 DNMBP | 2.17e-04 | 507 | 159 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.67e-04 | 118 | 159 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | Toll-like receptor 2 binding | 3.74e-04 | 4 | 159 | 2 | GO:0035663 | |
| GeneOntologyMolecularFunction | short-chain fatty acid transmembrane transporter activity | 6.20e-04 | 5 | 159 | 2 | GO:0015636 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 9.46e-07 | 44 | 156 | 6 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 1.82e-06 | 49 | 156 | 6 | GO:0050685 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | PDE3A BRIP1 SPATA31A3 RBMY1A1 SPATA31A7 MKRN2 RBMY1D RBMY1B RBMY1E SPATA20 VPS54 KATNAL1 RNF17 SPATA31A6 SPATA31A5 LHX1 MEI4 AXDND1 DMRT3 SPATA31A1 BRCA2 ZAR1 RNF38 CFAP157 VEGFA | 6.20e-06 | 1235 | 156 | 25 | GO:0003006 |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 8.09e-06 | 63 | 156 | 6 | GO:0033120 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell-granule cell precursor cell signaling | 5.68e-05 | 2 | 156 | 2 | GO:0021937 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 5.72e-05 | 129 | 156 | 7 | GO:0048024 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | PDE3A BRIP1 SPATA31A3 AVPR1A SPATA31A7 MKRN2 RBMY1B ETV6 SPATA20 DDO VPS54 KATNAL1 RNF17 SPATA31A6 SPATA31A5 OPRM1 MEI4 AXDND1 SPATA31A1 BRCA2 ZAR1 CFAP157 | 9.66e-05 | 1194 | 156 | 22 | GO:0048609 |
| GeneOntologyBiologicalProcess | gamete generation | PDE3A BRIP1 SPATA31A3 SPATA31A7 MKRN2 RBMY1B ETV6 SPATA20 VPS54 KATNAL1 RNF17 SPATA31A6 SPATA31A5 MEI4 AXDND1 SPATA31A1 BRCA2 ZAR1 CFAP157 | 1.62e-04 | 982 | 156 | 19 | GO:0007276 |
| GeneOntologyBiologicalProcess | spermatogenesis | BRIP1 SPATA31A3 SPATA31A7 MKRN2 RBMY1B SPATA20 VPS54 KATNAL1 RNF17 SPATA31A6 SPATA31A5 MEI4 AXDND1 SPATA31A1 BRCA2 CFAP157 | 1.69e-04 | 744 | 156 | 16 | GO:0007283 |
| GeneOntologyBiologicalProcess | detection of bacterial lipopeptide | 1.70e-04 | 3 | 156 | 2 | GO:0070340 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.83e-04 | 207 | 156 | 8 | GO:0043484 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 2.03e-04 | 158 | 156 | 7 | GO:0050684 | |
| GeneOntologyBiologicalProcess | insemination | 2.21e-04 | 16 | 156 | 3 | GO:0007320 | |
| GeneOntologyBiologicalProcess | male gamete generation | BRIP1 SPATA31A3 SPATA31A7 MKRN2 RBMY1B SPATA20 VPS54 KATNAL1 RNF17 SPATA31A6 SPATA31A5 MEI4 AXDND1 SPATA31A1 BRCA2 CFAP157 | 2.22e-04 | 762 | 156 | 16 | GO:0048232 |
| GeneOntologyCellularComponent | myosin complex | 8.59e-05 | 59 | 159 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.47e-04 | 215 | 159 | 8 | GO:0005681 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.90e-04 | 290 | 159 | 9 | GO:0043292 | |
| HumanPheno | Dystrophic fingernails | 3.98e-06 | 32 | 40 | 5 | HP:0008391 | |
| HumanPheno | Bilateral microphthalmos | 3.66e-05 | 25 | 40 | 4 | HP:0007633 | |
| Domain | RBM1CTR | 2.16e-09 | 8 | 157 | 5 | PF08081 | |
| Domain | RBM1CTR | 2.16e-09 | 8 | 157 | 5 | IPR012604 | |
| Domain | DUF4599 | 2.26e-06 | 12 | 157 | 4 | PF15371 | |
| Domain | DUF4599 | 2.26e-06 | 12 | 157 | 4 | IPR027970 | |
| Domain | Myosin_head_motor_dom | 1.58e-05 | 38 | 157 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.58e-05 | 38 | 157 | 5 | PS51456 | |
| Domain | Myosin_head | 1.58e-05 | 38 | 157 | 5 | PF00063 | |
| Domain | MYSc | 1.58e-05 | 38 | 157 | 5 | SM00242 | |
| Domain | Helicase_C_2 | 4.17e-04 | 4 | 157 | 2 | PF13307 | |
| Domain | DEAD_2 | 4.17e-04 | 4 | 157 | 2 | PF06733 | |
| Domain | DEAD_2 | 4.17e-04 | 4 | 157 | 2 | IPR010614 | |
| Domain | ATP-dep_Helicase_C | 4.17e-04 | 4 | 157 | 2 | IPR006555 | |
| Domain | Helicase-like_DEXD_c2 | 4.17e-04 | 4 | 157 | 2 | IPR006554 | |
| Domain | DNA_helicase_DNA-repair_Rad3 | 4.17e-04 | 4 | 157 | 2 | IPR013020 | |
| Domain | HELICASE_ATP_BIND_2 | 4.17e-04 | 4 | 157 | 2 | PS51193 | |
| Domain | Helic_SF1/SF2_ATP-bd_DinG/Rad3 | 4.17e-04 | 4 | 157 | 2 | IPR014013 | |
| Domain | DEXDc2 | 4.17e-04 | 4 | 157 | 2 | SM00488 | |
| Domain | HELICc2 | 4.17e-04 | 4 | 157 | 2 | SM00491 | |
| Domain | Znf_RING_CS | 4.62e-04 | 163 | 157 | 7 | IPR017907 | |
| Domain | Znf_RING/FYVE/PHD | RNF144B TRIML1 TRIM25 MKRN2 RNF113A NSD1 RNF17 ZFYVE9 RNF38 TRIM63 KDM2A BRD1 | 5.14e-04 | 459 | 157 | 12 | IPR013083 |
| Domain | IQ | 6.03e-04 | 81 | 157 | 5 | SM00015 | |
| Domain | Toll-like_receptor | 6.91e-04 | 5 | 157 | 2 | IPR017241 | |
| Domain | Cys-rich_flank_reg_C | 9.74e-04 | 90 | 157 | 5 | IPR000483 | |
| Domain | LRRCT | 9.74e-04 | 90 | 157 | 5 | SM00082 | |
| Domain | IQ_motif_EF-hand-BS | 9.74e-04 | 90 | 157 | 5 | IPR000048 | |
| Domain | OSR1_C | 1.03e-03 | 6 | 157 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.03e-03 | 6 | 157 | 2 | IPR024678 | |
| Domain | RING | 1.13e-03 | 305 | 157 | 9 | SM00184 | |
| Domain | IQ | 1.13e-03 | 93 | 157 | 5 | PS50096 | |
| Pubmed | 6.02e-14 | 7 | 160 | 6 | 8269511 | ||
| Pubmed | 7.79e-12 | 12 | 160 | 6 | 9598316 | ||
| Pubmed | 1.16e-11 | 6 | 160 | 5 | 20850414 | ||
| Pubmed | 1.16e-11 | 6 | 160 | 5 | 15184870 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.16e-11 | 6 | 160 | 5 | 25930072 | |
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 4.03e-11 | 7 | 160 | 5 | 8875892 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 2.15e-09 | 5 | 160 | 4 | 8817321 | |
| Pubmed | 2.15e-09 | 5 | 160 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 2.15e-09 | 5 | 160 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 2.15e-09 | 5 | 160 | 4 | 19737860 | |
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 6.42e-09 | 6 | 160 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 6.42e-09 | 6 | 160 | 4 | 12356914 | |
| Pubmed | 6.42e-09 | 6 | 160 | 4 | 9499427 | ||
| Pubmed | 6.42e-09 | 6 | 160 | 4 | 18239052 | ||
| Pubmed | 6.42e-09 | 6 | 160 | 4 | 15051956 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 1.49e-08 | 7 | 160 | 4 | 10377282 | |
| Pubmed | 1.49e-08 | 7 | 160 | 4 | 17001072 | ||
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 7479793 | ||
| Pubmed | 7.66e-08 | 24 | 160 | 5 | 32212159 | ||
| Pubmed | 8.87e-08 | 10 | 160 | 4 | 10601091 | ||
| Pubmed | 8.87e-08 | 10 | 160 | 4 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 2.07e-07 | 12 | 160 | 4 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 2.99e-07 | 13 | 160 | 4 | 23816659 | |
| Pubmed | 2.99e-07 | 13 | 160 | 4 | 10749975 | ||
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 4.17e-07 | 14 | 160 | 4 | 14611631 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 5.66e-07 | 15 | 160 | 4 | 14762062 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | RAPGEF6 TRIM25 LRRN1 TMEM151B NUMA1 CNKSR2 WNK1 ZNF804A MAP4K5 TPX2 RNF38 MGA | 8.13e-07 | 430 | 160 | 12 | 35044719 |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 9.80e-07 | 17 | 160 | 4 | 28115466 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 1.26e-06 | 18 | 160 | 4 | 12023983 | |
| Pubmed | MYH11 LRRN1 ARHGAP23 RALGAPA2 WNK1 ESCO1 FAT2 TLR1 KDM2A KAZN MGA ADAMTSL2 | 3.34e-06 | 493 | 160 | 12 | 15368895 | |
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 5.59e-06 | 55 | 160 | 5 | 19468303 | |
| Pubmed | 5.96e-06 | 26 | 160 | 4 | 35920200 | ||
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 20554749 | ||
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 23669529 | ||
| Pubmed | 7.93e-06 | 59 | 160 | 5 | 11279525 | ||
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 20809939 | ||
| Pubmed | Identification and Herc5-mediated ISGylation of novel target proteins. | 2.04e-05 | 12 | 160 | 3 | 16884686 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22315281 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11567052 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19563921 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26470427 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21852947 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19148513 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11123271 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29175392 | ||
| Pubmed | Myosin-7b Promotes Distal Tip Localization of the Intermicrovillar Adhesion Complex. | 2.10e-05 | 2 | 160 | 2 | 27666969 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28474755 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27582493 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 30917032 | ||
| Pubmed | BRCA2 promotes DNA-RNA hybrid resolution by DDX5 helicase at DNA breaks to facilitate their repair‡. | 2.10e-05 | 2 | 160 | 2 | 33634895 | |
| Pubmed | Mouse class III myosins: kinase activity and phosphorylation sites. | 2.10e-05 | 2 | 160 | 2 | 21895655 | |
| Pubmed | Analysis of ubiquitin E3 ligase activity using selective polyubiquitin binding proteins. | 2.10e-05 | 2 | 160 | 2 | 22721718 | |
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 2.10e-05 | 2 | 160 | 2 | 32473614 | |
| Pubmed | Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. | 2.10e-05 | 2 | 160 | 2 | 18036178 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24445834 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24984237 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25261617 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27074266 | ||
| Pubmed | A specific role for TLR1 in protective T(H)17 immunity during mucosal infection. | 2.10e-05 | 2 | 160 | 2 | 22778390 | |
| Pubmed | KSR2 NUMA1 ADGRB3 NSD1 TNRC6B SPATA20 CNKSR2 ZNF318 WASF2 SPHKAP SYNE2 PRKAR2A MGA WNK3 DCAF7 | 4.17e-05 | 963 | 160 | 15 | 28671696 | |
| Pubmed | 4.21e-05 | 42 | 160 | 4 | 23444366 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 4.43e-05 | 357 | 160 | 9 | 37059091 | |
| Pubmed | 5.10e-05 | 453 | 160 | 10 | 29656893 | ||
| Pubmed | 5.12e-05 | 16 | 160 | 3 | 28603487 | ||
| Pubmed | RAPGEF6 NUMA1 NSD1 TNRC6B BEND3 ZNF318 MIDEAS TPX2 KDM2A MGA DCAF7 | 5.14e-05 | 549 | 160 | 11 | 38280479 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 17079864 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 33342805 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 34905470 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 16081826 | ||
| Pubmed | Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. | 6.29e-05 | 3 | 160 | 2 | 18752252 | |
| Pubmed | Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1. | 6.29e-05 | 3 | 160 | 2 | 26974308 | |
| Pubmed | CMYA5 establishes cardiac dyad architecture and positioning. | 6.29e-05 | 3 | 160 | 2 | 35449169 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 15731092 | ||
| Pubmed | Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue. | 6.29e-05 | 3 | 160 | 2 | 20127022 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 27338800 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 32503626 | ||
| Pubmed | IFNs activate toll-like receptor gene expression in viral infections. | 6.29e-05 | 3 | 160 | 2 | 11607792 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 37311054 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 18451040 | ||
| Pubmed | TLR1- and TLR6-independent recognition of bacterial lipopeptides. | 6.29e-05 | 3 | 160 | 2 | 16455646 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 16177110 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 22150367 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20865662 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 1655529 | ||
| Pubmed | Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor. | 6.29e-05 | 3 | 160 | 2 | 33320834 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20589911 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 23626692 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 25579062 | ||
| Pubmed | Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. | 6.29e-05 | 3 | 160 | 2 | 15812078 | |
| Pubmed | Epistatic effect of TLR-1, -6 and -10 polymorphisms on organic dust-mediated cytokine response. | 6.29e-05 | 3 | 160 | 2 | 28123183 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20301776 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 25605403 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 14966134 | ||
| Pubmed | Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. | 6.29e-05 | 3 | 160 | 2 | 17932345 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 24112285 | ||
| Pubmed | Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. | 6.29e-05 | 3 | 160 | 2 | 12077222 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 18056480 | ||
| Pubmed | Myosin III-mediated cross-linking and stimulation of actin bundling activity of Espin. | 6.29e-05 | 3 | 160 | 2 | 26785147 | |
| Pubmed | TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes. | 6.29e-05 | 3 | 160 | 2 | 21998742 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 22280448 | ||
| Interaction | PAX2 interactions | 4.71e-06 | 85 | 158 | 7 | int:PAX2 | |
| Cytoband | Yq11.223 | 1.96e-05 | 93 | 160 | 5 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 3.33e-04 | 8 | 160 | 2 | chr9q12 | |
| Cytoband | 15q15.1 | 6.02e-04 | 47 | 160 | 3 | 15q15.1 | |
| GeneFamily | Myosins, class III|Deafness associated genes | 3.67e-05 | 2 | 110 | 2 | 1099 | |
| GeneFamily | Ring finger proteins | 2.78e-04 | 275 | 110 | 8 | 58 | |
| GeneFamily | ADAMTS like | 7.55e-04 | 7 | 110 | 2 | 947 | |
| GeneFamily | CD molecules|Toll like receptors | 1.60e-03 | 10 | 110 | 2 | 948 | |
| GeneFamily | RNA binding motif containing | 1.93e-03 | 213 | 110 | 6 | 725 | |
| GeneFamily | LIM class homeoboxes | 2.33e-03 | 12 | 110 | 2 | 522 | |
| GeneFamily | Fibronectin type III domain containing | 2.96e-03 | 160 | 110 | 5 | 555 | |
| GeneFamily | Myosin heavy chains | 3.66e-03 | 15 | 110 | 2 | 1098 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ZBTB20 TNRC6B VPS54 WNK1 RTF1 SYNE2 RNF38 MGA EIF2AK3 ZRANB1 WNK3 | 1.46e-06 | 289 | 157 | 11 | M2196 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 8.55e-06 | 169 | 157 | 8 | M39230 | |
| Coexpression | GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 2.79e-05 | 199 | 157 | 8 | M6001 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAST_CELL_UP | 2.79e-05 | 199 | 157 | 8 | M5397 | |
| Coexpression | KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN | 2.79e-05 | 199 | 157 | 8 | M3028 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 4.43e-05 | 33 | 157 | 4 | MM701 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-08 | 176 | 157 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.61e-08 | 190 | 157 | 9 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.90e-07 | 190 | 157 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.90e-07 | 190 | 157 | 8 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.90e-07 | 190 | 157 | 8 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.90e-07 | 190 | 157 | 8 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.06e-07 | 191 | 157 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-06 | 175 | 157 | 7 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.72e-06 | 181 | 157 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Control-NK_activated|Control / Disease condition and Cell class | 4.11e-06 | 119 | 157 | 6 | 0d0bab03d56e269c6e637b0bbeffe9d1491dfc33 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.15e-06 | 184 | 157 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.30e-06 | 185 | 157 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.30e-06 | 185 | 157 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.45e-06 | 186 | 157 | 7 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.95e-06 | 189 | 157 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-06 | 189 | 157 | 7 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.12e-06 | 190 | 157 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.30e-06 | 191 | 157 | 7 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.30e-06 | 191 | 157 | 7 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.68e-06 | 193 | 157 | 7 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.87e-06 | 194 | 157 | 7 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.87e-06 | 194 | 157 | 7 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 194 | 157 | 7 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.07e-06 | 195 | 157 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.07e-06 | 195 | 157 | 7 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.07e-06 | 195 | 157 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-06 | 196 | 157 | 7 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-06 | 196 | 157 | 7 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-06 | 196 | 157 | 7 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 6.49e-06 | 197 | 157 | 7 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.71e-06 | 198 | 157 | 7 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.16e-06 | 200 | 157 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.51e-05 | 88 | 157 | 5 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.51e-05 | 88 | 157 | 5 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.51e-05 | 88 | 157 | 5 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 155 | 157 | 6 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-05 | 157 | 157 | 6 | 6730b775308f45a2f3946016bdbb7f8e5b5efe49 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-05 | 157 | 157 | 6 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-05 | 159 | 157 | 6 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-05 | 163 | 157 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 167 | 157 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 168 | 157 | 6 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.14e-05 | 170 | 157 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 171 | 157 | 6 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 171 | 157 | 6 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 172 | 157 | 6 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.38e-05 | 104 | 157 | 5 | b5ca6e589f414e549f4990fe334d4ee54829b298 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 173 | 157 | 6 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 173 | 157 | 6 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 175 | 157 | 6 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-05 | 175 | 157 | 6 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.81e-05 | 176 | 157 | 6 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 179 | 157 | 6 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.19e-05 | 179 | 157 | 6 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-05 | 179 | 157 | 6 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.19e-05 | 179 | 157 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.32e-05 | 180 | 157 | 6 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 180 | 157 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.46e-05 | 181 | 157 | 6 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 181 | 157 | 6 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 4.46e-05 | 181 | 157 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-05 | 182 | 157 | 6 | f00eec1f434d92d44787d3d3343476c98c3de5b4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.74e-05 | 183 | 157 | 6 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.74e-05 | 183 | 157 | 6 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.88e-05 | 184 | 157 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 185 | 157 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 5.03e-05 | 185 | 157 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 185 | 157 | 6 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.03e-05 | 185 | 157 | 6 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 185 | 157 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-05 | 186 | 157 | 6 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-05 | 186 | 157 | 6 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 186 | 157 | 6 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 187 | 157 | 6 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.34e-05 | 187 | 157 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.34e-05 | 187 | 157 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 5.34e-05 | 187 | 157 | 6 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-05 | 187 | 157 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.34e-05 | 187 | 157 | 6 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 188 | 157 | 6 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 188 | 157 | 6 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-05 | 189 | 157 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 5.67e-05 | 189 | 157 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.67e-05 | 189 | 157 | 6 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.67e-05 | 189 | 157 | 6 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-05 | 189 | 157 | 6 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-05 | 190 | 157 | 6 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.83e-05 | 190 | 157 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.83e-05 | 190 | 157 | 6 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 5.83e-05 | 190 | 157 | 6 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.83e-05 | 190 | 157 | 6 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 190 | 157 | 6 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.83e-05 | 190 | 157 | 6 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 6.01e-05 | 191 | 157 | 6 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 6.01e-05 | 191 | 157 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.01e-05 | 191 | 157 | 6 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 191 | 157 | 6 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.01e-05 | 191 | 157 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.01e-05 | 191 | 157 | 6 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 191 | 157 | 6 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| Drug | hydantoin-5-propionic acid | 4.33e-09 | 21 | 154 | 6 | CID000000782 | |
| Disease | urinary albumin to creatinine ratio | 3.65e-05 | 179 | 149 | 7 | EFO_0007778 | |
| Disease | acoustic neuroma (is_implicated_in) | 7.57e-05 | 3 | 149 | 2 | DOID:12689 (is_implicated_in) | |
| Disease | protein C measurement | 8.15e-05 | 17 | 149 | 3 | EFO_0004633 | |
| Disease | triacylglycerol 60:12 measurement | 8.15e-05 | 17 | 149 | 3 | EFO_0010444 | |
| Disease | lean body mass | 1.39e-04 | 379 | 149 | 9 | EFO_0004995 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.41e-04 | 222 | 149 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 1.51e-04 | 4 | 149 | 2 | C2752089 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 1.51e-04 | 4 | 149 | 2 | cv:C5574675 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 1.51e-04 | 4 | 149 | 2 | cv:C2752089 | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 1.51e-04 | 4 | 149 | 2 | 201300 | |
| Disease | amyotrophic lateral sclerosis type 1 (implicated_via_orthology) | 1.51e-04 | 4 | 149 | 2 | DOID:0060193 (implicated_via_orthology) | |
| Disease | red blood cell density measurement | VLDLR HIVEP1 POLR1A ETV6 TNRC6B WNK1 RGS3 ZBTB37 ZNF106 FMN1 MAP4K5 TPX2 KDM2A ZRANB1 | 1.56e-04 | 880 | 149 | 14 | EFO_0007978 |
| Disease | body weight | HIVEP1 POLR1A KSR2 ADGRB3 ETV6 TNRC6B CNKSR2 OPRM1 GSE1 MAP4K5 SPHKAP KDM2A LTBP3 KAZN MGA EIF2AK3 ZRANB1 | 2.23e-04 | 1261 | 149 | 17 | EFO_0004338 |
| Disease | Geleophysic dysplasia | 2.51e-04 | 5 | 149 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 2.51e-04 | 5 | 149 | 2 | C0265287 | |
| Disease | brain glioma (is_marker_for) | 2.51e-04 | 5 | 149 | 2 | DOID:0060108 (is_marker_for) | |
| Disease | non-high density lipoprotein cholesterol measurement | VLDLR HIVEP1 NSD1 MIDEAS BRCA2 MAP4K5 PDGFD SYNE2 TRIM63 GEN1 BRWD1 VEGFA | 2.82e-04 | 713 | 149 | 12 | EFO_0005689 |
| Disease | Drug habituation | 3.02e-04 | 115 | 149 | 5 | C0013170 | |
| Disease | Drug abuse | 3.02e-04 | 115 | 149 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.02e-04 | 115 | 149 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 3.02e-04 | 115 | 149 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 3.02e-04 | 115 | 149 | 5 | C0013222 | |
| Disease | Drug Dependence | 3.02e-04 | 115 | 149 | 5 | C1510472 | |
| Disease | Substance Dependence | 3.02e-04 | 115 | 149 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 3.02e-04 | 115 | 149 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.02e-04 | 115 | 149 | 5 | C0029231 | |
| Disease | Substance abuse problem | 3.14e-04 | 116 | 149 | 5 | C0740858 | |
| Disease | 2-myristoyl-GPC (14:0) measurement | 3.75e-04 | 6 | 149 | 2 | EFO_0800242 | |
| Disease | 1-myristoyl-GPC (14:0) measurement | 3.75e-04 | 6 | 149 | 2 | EFO_0800221 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 3.75e-04 | 6 | 149 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | brain edema (implicated_via_orthology) | 3.75e-04 | 6 | 149 | 2 | DOID:4724 (implicated_via_orthology) | |
| Disease | Trichothiodystrophy Syndromes | 3.75e-04 | 6 | 149 | 2 | C1955934 | |
| Disease | monocyte count | VLDLR RASGRP4 AHI1 HIVEP1 ARHGAP23 BEND3 MED13L WNK1 GSE1 RCBTB1 MAP4K5 WASF2 TADA2B TBC1D14 TPX2 NLRC5 LSP1 | 3.78e-04 | 1320 | 149 | 17 | EFO_0005091 |
| Disease | body surface area | HIVEP1 POLR1A NSD1 ETV6 MED13L WNK1 OPRM1 MAP4K5 KDM2A LTBP3 EIF2AK3 | 4.43e-04 | 643 | 149 | 11 | EFO_0022196 |
| Disease | FEV/FEC ratio | PDE3A KSR2 NSD1 ETV6 CNKSR2 ATE1 DDX5 ZNF106 LLGL2 PTPRM SYNE2 THG1L RNF38 LTBP3 ARHGAP20 MGA | 4.99e-04 | 1228 | 149 | 16 | EFO_0004713 |
| Disease | chronotype measurement | HIVEP1 AVPR1A NAB1 TNRC6B ZNF318 ATE1 MED13L ZNF804A ZBTB37 AXDND1 KAZN EIF2AK3 IP6K2 | 5.56e-04 | 882 | 149 | 13 | EFO_0008328 |
| Disease | Schizophrenia | VLDLR AHI1 RAPGEF6 AVPR1A DDO CMYA5 ZNF804A OPRM1 NDST3 RCBTB1 CSPG5 BRD1 WNK3 | 5.62e-04 | 883 | 149 | 13 | C0036341 |
| Disease | aspergillosis (is_implicated_in) | 6.95e-04 | 8 | 149 | 2 | DOID:13564 (is_implicated_in) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 8.81e-04 | 84 | 149 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | vascular endothelial growth factor A, isoform 121 measurement | 8.91e-04 | 9 | 149 | 2 | EFO_0020847 | |
| Disease | estrogen measurement | 1.11e-03 | 10 | 149 | 2 | EFO_0011007 | |
| Disease | monocyte percentage of leukocytes | AHI1 POLR1A MKRN2 BEND3 MED13L WNK1 MAP4K5 TADA2B TBC1D14 TPX2 LSP1 | 1.26e-03 | 731 | 149 | 11 | EFO_0007989 |
| Disease | level of Ceramide (d40:1) in blood serum | 1.35e-03 | 11 | 149 | 2 | OBA_2045185 | |
| Disease | depressive symptom measurement | 1.50e-03 | 426 | 149 | 8 | EFO_0007006 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.58e-03 | 166 | 149 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | alcohol consumption measurement | CHDH ADGRB3 ZNF804A RGS3 OPRM1 NDST3 ZBTB37 MEI4 PTPRB MAP4K5 SPHKAP PRKAR2A BCAR3 MGA IP6K2 | 1.60e-03 | 1242 | 149 | 15 | EFO_0007878 |
| Disease | vascular endothelial growth factor A measurement | 1.62e-03 | 12 | 149 | 2 | EFO_0010804 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.62e-03 | 12 | 149 | 2 | C0023485 | |
| Disease | level of Phosphatidylcholine (14:0_18:1) in blood serum | 1.62e-03 | 12 | 149 | 2 | OBA_2045062 | |
| Disease | JT interval | 1.68e-03 | 248 | 149 | 6 | EFO_0007885 | |
| Disease | xanthine measurement | 1.90e-03 | 13 | 149 | 2 | EFO_0010548 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 1.90e-03 | 13 | 149 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 1.90e-03 | 13 | 149 | 2 | C0270914 | |
| Disease | Drugs used in diabetes use measurement | 1.93e-03 | 255 | 149 | 6 | EFO_0009924 | |
| Disease | apolipoprotein B measurement | VLDLR ERCC2 MKRN2 MIDEAS BRCA2 MAP4K5 PDGFD SYNE2 BRWD1 VEGFA | 2.05e-03 | 663 | 149 | 10 | EFO_0004615 |
| Disease | Fanconi anemia | 2.21e-03 | 14 | 149 | 2 | cv:C0015625 | |
| Disease | triacylglycerol 46:2 measurement | 2.21e-03 | 14 | 149 | 2 | EFO_0010402 | |
| Disease | caudate volume change measurement | 2.21e-03 | 14 | 149 | 2 | EFO_0021491 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.21e-03 | 14 | 149 | 2 | C0677776 | |
| Disease | gallstones | 2.23e-03 | 108 | 149 | 4 | EFO_0004210 | |
| Disease | Abnormality of refraction | PDE3A BRIP1 CHDH KSR2 CNKSR2 KATNAL1 RGS3 DDX5 RCBTB1 MAP4K5 | 2.29e-03 | 673 | 149 | 10 | HP_0000539 |
| Disease | skin aging measurement | 2.31e-03 | 181 | 149 | 5 | EFO_0008006 | |
| Disease | corpus callosum posterior volume measurement | 2.33e-03 | 52 | 149 | 3 | EFO_0010298 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.46e-03 | 111 | 149 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 2.55e-03 | 15 | 149 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.88e-03 | 56 | 149 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.88e-03 | 56 | 149 | 3 | EFO_0022251 | |
| Disease | Spondyloepiphyseal Dysplasia | 2.90e-03 | 16 | 149 | 2 | C0038015 | |
| Disease | triacylglycerol 50:5 measurement | 2.90e-03 | 16 | 149 | 2 | EFO_0010412 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.90e-03 | 16 | 149 | 2 | C3541456 | |
| Disease | anthranilic acid measurement | 2.90e-03 | 16 | 149 | 2 | EFO_0010460 | |
| Disease | colorectal mucinous adenocarcinoma | 2.90e-03 | 16 | 149 | 2 | EFO_0009361 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.90e-03 | 16 | 149 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 2.90e-03 | 16 | 149 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.90e-03 | 16 | 149 | 2 | C0025237 | |
| Disease | body composition measurement | 3.04e-03 | 193 | 149 | 5 | EFO_0005106 | |
| Disease | Colorectal Carcinoma | ERCC2 CNKSR2 WNK1 ZNF804A NDST3 ZNF385D GSE1 PDGFD TPX2 KDM2A | 3.09e-03 | 702 | 149 | 10 | C0009402 |
| Disease | Van Buchem disease | 3.28e-03 | 17 | 149 | 2 | C0432272 | |
| Disease | caudal anterior cingulate cortex volume measurement | 3.28e-03 | 17 | 149 | 2 | EFO_0010289 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.28e-03 | 17 | 149 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.36e-03 | 121 | 149 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | IGF-1 measurement | 3.46e-03 | 488 | 149 | 8 | EFO_0004627 | |
| Disease | triglycerides to total lipids in large HDL percentage | 3.50e-03 | 60 | 149 | 3 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 3.50e-03 | 60 | 149 | 3 | EFO_0022237 | |
| Disease | eosinophil count | RASGRP4 RAPGEF6 HIVEP1 MKRN2 BEND3 WNK1 RTF1 DUS2 GSE1 MAP4K5 TBC1D14 NLRC5 LTBP3 MUC5AC ZRANB1 IP6K2 | 3.57e-03 | 1488 | 149 | 16 | EFO_0004842 |
| Disease | Bone marrow hypocellularity | 3.67e-03 | 18 | 149 | 2 | C1855710 | |
| Disease | Hemangiosarcoma | 3.67e-03 | 18 | 149 | 2 | C0018923 | |
| Disease | lysophosphatidylcholine measurement | 3.84e-03 | 62 | 149 | 3 | EFO_0010224 | |
| Disease | cutaneous melanoma, hair color | 3.84e-03 | 62 | 149 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 3.99e-03 | 127 | 149 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Osteochondrodysplasias | 4.09e-03 | 19 | 149 | 2 | C0029422 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 4.09e-03 | 19 | 149 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | Dyschondroplasias | 4.09e-03 | 19 | 149 | 2 | C0013366 | |
| Disease | triglyceride measurement, body mass index | 4.09e-03 | 19 | 149 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | Tinnitus | 4.34e-03 | 130 | 149 | 4 | HP_0000360 | |
| Disease | Multiple Epiphyseal Dysplasia | 4.53e-03 | 20 | 149 | 2 | C0026760 | |
| Disease | total lipids in very large HDL measurement | 4.58e-03 | 66 | 149 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 4.58e-03 | 66 | 149 | 3 | EFO_0022298 | |
| Disease | neutrophil count, eosinophil count | 4.62e-03 | 213 | 149 | 5 | EFO_0004833, EFO_0004842 | |
| Disease | Calcium channel blocker use measurement | 4.62e-03 | 213 | 149 | 5 | EFO_0009930 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLPHRRKQIISCNIC | 71 | Q9H6B1 | |
| ERPPVCLRTKRHKNN | 81 | O95696 | |
| RRSRTCQLPTVQLHP | 66 | Q6UY14 | |
| EGSHPNVRKLCNTPR | 481 | O95196 | |
| NVRKLCNTPRTSSPH | 486 | O95196 | |
| PHPHRQRKESETQCQ | 546 | Q9NZJ5 | |
| IERKPCNHQVDTAPT | 1041 | Q8N157 | |
| QPINRTVPLRCLEEH | 251 | O75815 | |
| TTQVCNLTREAKRPP | 236 | O60242 | |
| VRAHLRCVAEQPPLK | 771 | Q14687 | |
| NAVSPKLLSRHRPTC | 656 | Q6XZF7 | |
| HLLPTPELSSKRNQC | 26 | P0CE67 | |
| TVATRPQKAACPHQE | 411 | Q5JU67 | |
| DVRVPCTPVARLNNH | 251 | P61962 | |
| PCSVLVSLLQKPRHR | 396 | A8MX76 | |
| CTRPITLHSAQKPLR | 346 | Q8NE62 | |
| CRLQVLHPFDPEQRK | 196 | Q9H000 | |
| KDCCINPHSPLIRVT | 191 | O95803 | |
| REHVCRKDQRNPPSL | 446 | P0DJD3 | |
| REHVCRKDQRNPPSL | 446 | A6NDE4 | |
| REHVCRKDQRNPPSL | 446 | P0DJD4 | |
| REHVCRKDQRNPPSL | 446 | P0C7P1 | |
| REHVCRKDQRNPPSL | 446 | A6NEQ0 | |
| REHVCRKDQRNPPSL | 446 | Q15415 | |
| ANQPTPRKVTNCLHI | 166 | Q8NDN9 | |
| LTPRQKERAASPHQV | 2461 | Q96L73 | |
| RHQKTQTVPDCRDPA | 186 | P49796 | |
| PPKTFRNVCVQTDRE | 796 | Q68DA7 | |
| QEHLPTSVKSEPRAC | 6 | Q9UH64 | |
| CRDSQPIVLPTEHRA | 166 | Q7Z419 | |
| QQRKVHVPGPECRDL | 656 | Q5T5X7 | |
| NCVQRTPRPSVDNVH | 156 | P41212 | |
| VVTSCQPKNPRELHR | 71 | Q9NUD7 | |
| VRTKPDKIQNLHCRP | 1351 | P23467 | |
| VCHPVKALDFRTPRN | 171 | P35372 | |
| AVRVSPCHSRQPSVI | 306 | Q674X7 | |
| CQCRRPLPTQIHIKS | 1756 | Q71F56 | |
| PRCLVDSAETKNHRP | 931 | Q6P1M3 | |
| NPDSPRCSKHNRLCI | 501 | Q8TAT5 | |
| IHTIIRKRAPPCNND | 1036 | Q8IWI9 | |
| NETTLCKPLVPREHQ | 36 | Q9UHH9 | |
| SISRVPHPKLCTRKN | 171 | P61550 | |
| RSSNAREPHLKIPKC | 116 | Q13506 | |
| ISLNRSLPDIRHPNC | 121 | Q86SR1 | |
| IRTHLSQSPRVPSKC | 191 | Q6VAB6 | |
| EITVRGHNCPKPVLN | 81 | P17844 | |
| VTLNPDQCHPSRKRR | 236 | Q9NR23 | |
| DQCHPSRKRRAAIPV | 241 | Q9NR23 | |
| TTRPPCVEDLHRQAK | 96 | Q5SYE7 | |
| LRATQPHFVRCIVPN | 711 | A7E2Y1 | |
| CGHKEVPPRIKSRTN | 131 | Q9GZP0 | |
| NSPQCITEHNRLKVP | 921 | Q9NYQ8 | |
| EVPKSLVSNLRIHCP | 61 | P80217 | |
| KSHRRTSLPCIPREQ | 306 | Q14432 | |
| QVRRHKTCPSPREIS | 26 | Q8TDF6 | |
| ERHCLQQRRKSVPGP | 71 | Q86TH1 | |
| SRKNLCIHPEVTPLR | 111 | P18074 | |
| ATPKPTRHIREQLAQ | 201 | P48742 | |
| ATPKPTRHIREQLAQ | 201 | Q9H2C1 | |
| TERLCSQNPPVLKRH | 1651 | P00451 | |
| TVNVCRDITRPPKTV | 2046 | P98088 | |
| PEEITRLQCRAKSHP | 3561 | P98088 | |
| CQKPQLHNPSRLRTR | 596 | Q68DD2 | |
| CTVVRPEKKRVTHNP | 51 | O15541 | |
| DQDILNTIIRHCPPR | 1051 | Q2PPJ7 | |
| EVHPNRRPKILAQTA | 106 | Q9Y4U1 | |
| KRPHQSCGSSPRRKQ | 121 | Q86WI3 | |
| SECVHALRTPIPKSN | 326 | Q99489 | |
| IRPLETTQQIRKRHC | 161 | Q9BX63 | |
| PQCAPRKDRQVHLTH | 441 | Q9Y2K7 | |
| VENPAPHCRRKSQEK | 421 | P0C671 | |
| LPRVDKRNPEHCVNS | 2106 | P51587 | |
| APLQRTPKCARCRNH | 21 | Q9NQL9 | |
| PVPSRTRINNPACHK | 441 | Q6P158 | |
| TRINNPACHKTVIPN | 446 | Q6P158 | |
| REKAVCPPHLARSLQ | 141 | Q5T1B0 | |
| QRKPISSIHAREPQS | 2131 | Q8N3K9 | |
| RHPKDNSPVVLACLI | 16 | P01880 | |
| CRSRPPAHRIKQQSE | 581 | Q494V2 | |
| VPEKVPRRCATVAAN | 2226 | Q9NSI6 | |
| PEHQCQHPLTTRLTR | 411 | Q9NS15 | |
| QNPAEHKPSVIVTRR | 556 | Q6PJG2 | |
| EHQKCQQPRTPSPLV | 166 | P33241 | |
| TIRCRPLQFQPSKSH | 76 | O95260 | |
| CNVRPPNTALDHSRK | 766 | Q17RS7 | |
| HNTRQPPEQKIRVSV | 156 | P50053 | |
| PRVIHPKTDEQRCRL | 116 | P13861 | |
| PHILQKPFNVTETRC | 281 | Q8IYX8 | |
| SDNRETPRNHSLPKC | 566 | Q5FWF5 | |
| NRIHPELPRVTRCHN | 621 | Q96QF7 | |
| KREERPQHPVSCEVI | 186 | Q9NX74 | |
| SCRPDRNEPHRIQQI | 351 | Q9BY41 | |
| IQKERPRLQTTFCTP | 301 | Q8IXS0 | |
| SNLRPEKCRRFVHPQ | 81 | Q6T423 | |
| PVRDDNKRQHPCLVE | 906 | Q92736 | |
| SKISVLEPPQEHRIC | 201 | Q8N4N8 | |
| LEPPQEHRICVCVRK | 206 | Q8N4N8 | |
| KSATPVCEAPRQHQL | 161 | Q6J272 | |
| PNLREISIHSNPLRC | 361 | Q6UXK5 | |
| PCKHLQTPCAELQRR | 551 | Q8WUT4 | |
| KHCPDSESRAPQILR | 416 | Q9Y4K4 | |
| PCTRTPHFLRIQNVE | 181 | P28827 | |
| AELQQRNRVCPPHLK | 1921 | Q14980 | |
| CHPSENRQVILLQVP | 491 | Q01101 | |
| VKRPCAILQNPLSSH | 136 | A8MW99 | |
| LKGPRTHRRCSEPNI | 836 | Q9P2F6 | |
| RRQCKPTIVSNSRDP | 596 | Q92541 | |
| IQRHCQSVRDPAIKG | 36 | Q9BW62 | |
| SSCQDPVPINHKRRS | 1406 | Q2M3C7 | |
| PVPINHKRRSLCSRE | 1411 | Q2M3C7 | |
| GHPNKVICERVRLQS | 16 | Q9H0F5 | |
| CVPSKIVTQPQRHNL | 1561 | Q8TEU7 | |
| KRQRIIEESTHCGPQ | 811 | O95602 | |
| RPEPTEVLHACKTQV | 4231 | Q8WXH0 | |
| QRPIQPSFTKSLCRE | 46 | Q8IW70 | |
| KACIPDTIPNRVTDH | 121 | Q86TJ2 | |
| EPEPSTACPQKQRHR | 286 | Q8N967 | |
| TACPQKQRHRPASVR | 291 | Q8N967 | |
| VINSKPDERPRLSHC | 156 | Q9H6L5 | |
| LHPRVSVSQDPRKLC | 986 | Q5VVP1 | |
| SNLRPEKCRRFVHPQ | 81 | Q63ZE4 | |
| HPRVSVSQDPRKLCL | 991 | Q8IWB4 | |
| AEPVKRQPRSQCLST | 346 | O00506 | |
| RCLPPRIKVLDLHSN | 441 | Q15399 | |
| SPEHRRQSTLPTQKC | 801 | Q8WXI2 | |
| TTPNFVRCIIPNHEK | 671 | P35749 | |
| TKPVVILPCQHNLCR | 31 | Q969Q1 | |
| TRKPCSPTRLFVHEV | 496 | Q9BXT8 | |
| PEPVPCSAVHVRRKQ | 76 | Q9P2M4 | |
| HPRVSVSQDPRKLCL | 991 | Q5VYP0 | |
| QCPVTQKPRLTRTAV | 241 | Q96QD9 | |
| KSVASRCKPQAPNHR | 151 | Q6ICB4 | |
| AELSQTRTKHQERPP | 136 | Q5TC79 | |
| IHPENKTVIVRCSQP | 231 | Q13496 | |
| HPRVSVSQDPRKLCL | 991 | Q5TZJ5 | |
| HPRVSVSQDPRKLCL | 991 | Q5VU36 | |
| AVTRTRTKPVPLHCD | 266 | Q9NWX6 | |
| RVPPSRLECQQALSH | 276 | Q9P227 | |
| STPQRVPNRLIHEKS | 56 | Q8TB22 | |
| QPPVRDLLRRKCSQH | 146 | Q14258 | |
| RRQRKHCITEDTPPT | 641 | Q9P2H5 | |
| QRVHRAAPACSPKEE | 521 | Q96BV0 | |
| REACPHQLLTQPRKT | 206 | Q9BY14 | |
| PTKRPALCIQKRHSS | 216 | Q2NKQ1 | |
| AKLCRPVHTRVTQNA | 196 | Q658L1 | |
| NHVVPIRPVSQKRSN | 261 | Q658L1 | |
| RCLPPRIKVLDLHSN | 446 | Q9Y2C9 | |
| IAVCHPLKTLQQPAR | 151 | P37288 | |
| RNIEPRHLCRQTLPS | 6 | Q9Y6W5 | |
| PETTHCRKQPRPVRI | 306 | Q9HC78 | |
| VSSPLKGQHVREPVC | 391 | Q8N9V2 | |
| VTIPRPHQIRCNCVE | 166 | Q9UL62 | |
| RTPPIIHRDLKCDNI | 341 | Q9H4A3 | |
| PCSERRKHLFVQDPQ | 186 | P15692 | |
| QRVPVEARPRKCETH | 161 | Q15937 | |
| AETELVPCSLRHPRQ | 71 | Q96M66 | |
| PAHRSPTVLCQKVCE | 2031 | Q5VUA4 | |
| RELSTSPCNPIVRQK | 636 | Q9H2Y7 | |
| CNPSLPKHNVTIRSD | 1066 | P15822 | |
| AKRCVVCDHPRPNNI | 166 | Q9UGI0 | |
| LNRPKTEGRSVNHLC | 216 | O95405 | |
| VPPRFRCQQDHKVLL | 91 | Q9UPQ9 | |
| QREKIHERCKNICPP | 126 | Q9P1Q0 | |
| QTRCSCPVKLRHVDP | 381 | Q86SH2 | |
| QCEPFVPVLNKHRST | 421 | Q7Z570 | |
| DPQTPVLQTKHRARA | 366 | Q9ULW0 | |
| RQPVIHTKCPASEIQ | 231 | P98155 | |
| TRTPPIIHRDLKCDN | 266 | Q9BYP7 | |
| PHFVRCIKPNSERQA | 946 | Q8NEV4 | |
| AQKHRTPRRRCQQPK | 1251 | Q8WXR4 | |
| CEPLRQPLLKRVHAN | 1646 | Q6PIF6 | |
| QQPIPTRVCKVSDLH | 751 | Q5VTT5 |